Polymyxin B1 I is a potent polymyxin antibiotic within the colistin family, primarily indicated for treating severe Gram-negative bacterial infections, including those involving multidrug-resistant pathogens… Read more
Polymyxin B1 I is a potent polymyxin antibiotic within the colistin family, primarily indicated for treating severe Gram-negative bacterial infections, including those involving multidrug-resistant pathogens like Pseudomonas aeruginosa. By disrupting bacterial cell membrane integrity, this compound effectively induces cell death. To support rigorous pharmaceutical development and regulatory compliance, high-quality reference standards are essential. Laboratories utilize these compounds, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labeled analogs, for precise impurity profiling and method validation. These analytical materials enable researchers to identify, quantify, and monitor degradation products and process-related impurities, ensuring the safety and efficacy of the final drug product. Accessing a comprehensive range of these related compounds is critical for maintaining robust quality control and accurate characterization of antibiotic formulations throughout the lifecycle of the drug.